These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17067603)

  • 21. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
    Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
    J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemochromatosis gene modifies course of hepatitis C viral infection.
    Pietrangelo A
    Gastroenterology; 2003 May; 124(5):1509-23. PubMed ID: 12730889
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correlation between hepatic immunological markers and virus genotype in patients with chronic hepatitis C].
    Yu WH; Li WX; Zhou DQ; He JS; Dong JM; Song ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):452-5. PubMed ID: 16883540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of the HFE gene in patients with hepatocellular carcinoma.
    Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
    Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype.
    Beutler E; Waalen J; Gelbart T
    Blood Cells Mol Dis; 2005; 35(3):326-7. PubMed ID: 16154780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hfe acts in hepatocytes to prevent hemochromatosis.
    Vujić Spasić M; Kiss J; Herrmann T; Galy B; Martinache S; Stolte J; Gröne HJ; Stremmel W; Hentze MW; Muckenthaler MU
    Cell Metab; 2008 Feb; 7(2):173-8. PubMed ID: 18249176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
    Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
    Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
    Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
    Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body iron stores and iron restoration rate in Japanese patients with chronic hepatitis C as measured during therapeutic iron removal revealed neither increased body iron stores nor effects of C282Y and H63D mutations on iron indices.
    Shiono Y; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Yano M; Yoshioka K; Saito H
    Nagoya J Med Sci; 2001 May; 64(1-2):51-7. PubMed ID: 11486601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
    Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
    Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic hemochromatosis and the HFE gene].
    Moirand R
    Bull Acad Natl Med; 2000; 184(2):325-35; discussion 335-6. PubMed ID: 10989541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
    Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
    Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C and iron.
    Olynyk JK
    Keio J Med; 1999 Sep; 48(3):124-31. PubMed ID: 10535273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic hemochromatosis update.
    Brissot P; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Loréal O
    Acta Gastroenterol Belg; 2005; 68(1):33-7. PubMed ID: 15832585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patients.
    Swinkels DW; Venselaar H; Wiegerinck ET; Bakker E; Joosten I; Jaspers CA; Vasmel WL; Breuning MH
    Blood Cells Mol Dis; 2008; 40(3):334-8. PubMed ID: 18042412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genes that modify the hemochromatosis phenotype in mice.
    Levy JE; Montross LK; Andrews NC
    J Clin Invest; 2000 May; 105(9):1209-16. PubMed ID: 10791995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.